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Primary brain tumors are the most common solid neoplasms of childhood, 
representing 20% of all pediatric tumors. The best current estimates place the 
incidence between 2.76 and 4.28/100,000 children per year. Compared with 
brain tumors in adults, a much higher percentage of pediatric brain tumors 
arise in the posterior fossa. Infratentorial tumors comprise as many as two thirds 
of all pediatric brain tumors in some large series. Tumor types that most often 
occur in the posterior fossa include medulloblastoma, ependymoma, cerebellar 
astrocytoma and brainstem glioma. 
Materials & Methods 
All pediatric cases of posterior fossa tumor that were considered for surgery 
from 1981 to 2011 were selected and the demographic data including age, 
gender and tumor characteristics along with the location and pathological 
diagnosis were recorded. The surgical outcomes were assessed according to 
pathological diagnosis.
Results 
Our series consisted of 84 patients (52 males, 32 females). Cerebellar 
symptoms were the most common cause of presentation (80.9%) followed 
by headache (73.8%) and vomiting (38.1%). The most common histology 
was medulloblastoma (42.8%) followed by cerebellar astrocytoma (28.6%), 
ependymoma (14.3%), brainstem glioma (7.2%) and miscellaneous pathologies 
(e.g., dermoid,  andtuberculoma) (7.2%). 
Conclusion
The diagnosis of brain tumors in the general pediatric population remains 
challenging. Most symptomatic children require several visits to a physician 
before the correct diagnosis is made. These patients are often misdiagnosed 
for gastrointestinal disorders. Greater understanding of the clinical presentation 
of these tumors and judicious use of modern neuroimaging techniques should 
lead to more efficacious therapies.
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Introduction
Posterior fossa tumors constitute about two thirds of pediatric tumors in large scale 
studies (1). This pattern is seen especially in children younger than 10 years of 
age. This is in contrast with adult series. Medulloblastoma, ependymoma, cerebellar 
astrocytoma and brainstem glioma are the most common posterior fossa tumors 
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in children. Hemangioblastoma, meningioma, sarcoma, 
chordoma and metastasis–mainly neuroblastoma, 
Wilms’ tumor and embryonal rhabdomyosarcoma–are 
other scarce posterior fossa tumor types (3).
Due to the raised intracranial pressure caused by 
hydrocephalus or tumor mass, children with posterior 
fossa tumors generally present with symptoms such 
as headache, nausea, vomiting, restlessness and poor 
feeding (4). Infants may present with macrocephaly and 
bulging fontanels. Cerebellar symptoms, particularly 
ataxia (difficulty with balance and coordination), 
are a frequent complaint of patients with posterior 
fossa tumors that invade or exert mass effect on the 
cerebellum or on the cerebellar peduncles. As a result of 
recumbency and rise of PaCO2, ICP increases leading 
to worsening of symptoms in the morning. In cases 
with delayed diagnosis, cerebellar symptoms are more 
commonly detected. On physical examination, cerebellar 
manifestations and nystagmus are common in posterior 
fossa tumor patients. In patients with hydrocephalus, 
papilledema may be observed. Continuous evaluation of 
the altered level of alertness is necessary (5, 6). 
In this paper we intend to report the 30-year experience 
and long-term assessment of surgical outcome on a 
large series of patients. An important feature of our 
study is that patient selection and all the surgical 
procedures and follow-up studies were performed by a 
single surgical team.
Materials & Methods
From March 1981 to December 2011, all pediatric 
patients who were referred to the neurosurgical clinic and 
were operated for posterior fossa tumor were evaluated.
Inclusion criteria were age equal or less than 14 years and 
evidence of posterior fossa tumor in the neuroimaging 
studies. The exclusion criteria were age more than 14 
years, prior surgery in another center and the parents’ 
unwillingness to perform surgery. The recorded data 
included age and sex distribution, duration and nature 
of symptoms, whether a pre or postoperative ventriculo-
peritoneal (V-P) shunt was inserted, tumor type on 
histological examination and surgical outcome.The 
statistical analysis was performed by Wilcoxon & Fisher 
methods and a p-value less than 0.05 was considered 
statistically significant.
Results
The study included 84 patients (52 males, 32 females; 
M/F ratio, 1.62; Mean age, 8.6 years; range. 1-14 years; 
standard deviation, 3.4 years). 
In our series, 50%(42 cases) of pediatric posterior fossa 
tumors occurred in children less than five years, 30% (25 
cases) in the 6-10 year age group and 20% (17 cases) 
occurred in older children (11-14 years).
The duration of symptoms from the beginning to the 
time of surgery ranged from 3 days to 4 years. The 
average value was 16 months and the standard deviation 
was 32 months. 
Cerebellar symptoms were the most common cause of 
presentation (80.9%) followed by headaches (73.8%) 
and vomiting (38.1%). Visual problems were found in 
7.14% of our patients probably due to late presentation. 
Neck stiffness was described in 2.3% of our patients. 
The most commonly involved cranial nerve was 
abducens nerve palsy which occurred mainly in cases 
with hydrocephalus (Table 1).
In our operated cases, the most common histology 
was medulloblastoma (42.8%) followed by cerebellar 
astrocytoma (28.6%), ependymoma (14.3%), brainstem 
glioma (7.2%) and miscellaneous pathologies (such 
asdermoid and tuberculoma) (7.2%) (Table 2).
In 25 patients, (30%) ventriculoperitoneal (VP) shunts 
were inserted before tumor resection due to severe 
hydrocephalus and poor general condition of the 
patients. In four patients (4.7%), a VP shunt was inserted 
post-operatively while the other patients (66.3%) did 
well without a shunt procedure.
In 70%, gross total resection of the tumor was performed. 
In 24%, the tumor was resected subtotally and in 6%, we 
performed partial tumor resection due to severe adhesion 
to the brain stem and involvement of the cranial nerves. 
The mean follow-up period was 78 months (range, 6 
months-18 years). 
The most common complication was superficial wound 
discharge that occurred in nine cases (10.7%). Twelve 
patients (14.3%) developed pseudomeningocele which 
responded to either medical treatment or VP shunt 
insertion. Cerebellar mutism or posterior fossa syndrome 
occurred in 14 patients (16.6 %) after a posterior 
fossa tumor resection. Early postoperative mortality 
occurred in two cases (2.4 %). One (1.2%) was due to 
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its side effects.
Most cerebellar astrocytomas are low grade pilocytic 
astrocytomas. In our study, this tumor was seen in 28.6% 
of our patients. These are mostly cystic with a mural 
module. Solid astrocytomas usually found in the vermis 
are more aggressive with a poor prognosis depending on 
the histological grade. However, of all childhood tumors, 
cerebellar astrocytoma has the best prognosis (15).
Ependmomas arise from the ependymal lining of the 
ventricles (4th ventricle in the posterior fossa). They 
are mostly benign but fast growing tumors (13). They 
recur frequently and tend to seed along cerebral-spinal 
fluid pathways. They are reddish grey, lobulated tumors 
and microscopically have a diagnostic feature of rosette 
formation.
Brainstem gliomas account for 25% of tumors arising 
in the posterior fossa in children; however, in our series 
only 7.2% of the patients had this pathology. They 
present with multiple cranial nerve palsies, signs of long 
tract involvement and imbalance of movement.
Classically, they present with diplopia due to involvement 
of the 4th and 6th cranial nerves. Blockage of the aqueduct 
leads to signs of raised intracranial pressure. Brain stem 
gliomas are classified into diffuse tumors, which balloon 
the brainstem and involve all layers. These are malignant 
with a very poor prognosis. They involve several cranial 
nerves particularly the fifth, sixth, seventh and the tenth 
cranial nerves.The other group are the focal tumors that 
lie within the brainstem and finally exophytic tumors 
that arise from the brainstem, but extend into the cavity 
of the fourth ventricle.
Both focal and exophytic brainstem tumors are usually 
pilocytic and surgery is the treatment of choice, unlike the 
diffuse type which is malignant and only chemotherapy 
and radiotherapy can palliate (16).
The discrepancy between tumor types in our series 
compared to other studies could be explained by the fact 
that our study was based only on operated cases in our 
institute not an epidemiologic survey. 
Although the correlation between posterior fossa tumors 
and hydrocephalus has been established, its incidence is 
not clear. It has been reported that in midline tumors, 
hydrocephalus is seen in 50% of the cases and when the 
location is hemispheric, hydrocephalus is seen in 20% of 
these cases (17). Twenty to thirty percent of brain stem 
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postoperative edema and the other (1.2 %) occurred after 
protracted meningitis.
Discussion
Tumors of the central nervous system are the second 
most common childhood tumors (20%) after leukemia 
(37%) and the most common solid pediatric tumors 
comprising 40-50% of all tumors (7,8).
Posterior fossa (infratentorial) tumors comprise 54% to 
70% of childhood brain tumors compared to 15%-20% 
in the adult population (9). Worldwide, the most common 
pediatric posterior fossa tumors are medulloblastoma 
(20%), astrocytoma (15%), brainstem glioma (15%) and 
ependymoma (8%) (10).
The estimated incidence of brain tumors in children is 
2-3.5 per 1 00,000 (11). The mean age at diagnosis has 
decreased from about 13 years in 1930 (12), nine years 
in 1970 (13) to the current figure of 6.5 years in 2010 
(9). In our study,the mean age at diagnosis was 8.6 years.
The clinical presentation of a child with posterior fossa 
mass is dependent on the anatomical location, histology 
type and the presence or absence of hydrocephalus 
(14). Because posterior fossa is only one tenth of the 
intracranial volume and contains structures that are 
responsible for vital functions, tumors in this region are 
quite challenging for the health care team.
Symptoms result from either compression of vital 
structures or raised intracranial pressure. Common 
presenting features include cerebellar symptoms, 
multiple cranial nerve palsies, headaches, vomiting and 
blindness due to raised intracranial pressures (15).
Medulloblastoma is the most common primary 
neuroectodermal tumor and also the most common solid 
childhood tumor. It comprises approximately 20% of 
posterior fossa tumors in childhood (16). In our study 
the tumor constituted 42.7% of the cases. They are 
extremely malignant tumors and are characterized by 
the ability to seed along cerebral spinal fluid pathways. 
The tumors are diffusely blue in color on staining and 
are often called blue tumors. They are treated surgically 
and in most cases, complete macroscopic removal is 
possible. Controversy exists on whether to perform pre 
or post operative shunting procedure. Adjuvant therapy 
involves chemotherapy or radiotherapy. Radiotherapy 
however is not given to children less than 4 years due to 
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pseudomeningocele and meningitis. In our patients there 
were no differences in the occurrence of contusion, 
upward cerebellar herniation and fatal intracranial 
hemorrhage between those who received preoperative 
shunting and those who did not. We had no evidence of 
death due to abdominal metastasis.
One of the most important issues in surgery of posterior 
fossa tumors is posterior fossa syndrome or cerebellar 
mutism. Cerebellar mutismwas first reported in 1979 
by Hirsh also known as posterior fossa syndrome (26). 
After posterior fossa surgery, the patients manifestations 
include cerebellar dysfunction, apraxia, emotional lability 
and mutism. The cause may be dentatothalamocortical 
tract injury ( 27). It occurred in 15% of our cases. In 
our study, factors associated with the development of 
mutism were an age less than 10 years, midline tumor 
location, cerebellar vermal incision and large tumor size 
(>5cm) and medulloblastoma. 
In conclusion, primitive neuroectodermal tumor 
(including medulloblastoma) and gliomas are the most 
common tumors in our children. The children presenting 
to us come very late in the course of their illness, when 
tumors attain very large size and become inoperable 
at times. These patients are often misdiagnosed for 
gastrointestinal disorders. Increased attention of 
pediatricians, teamwork and multidisciplinary approach 
to the complaints along with advances in neuroimaging 
techniques are prerequisite for the early diagnosis and 
the best surgical outcome of posterior fossa tumors in 
children.
gliomas showed hydrocephalus in a study conducted 
by Hojer et al. (18). In other studies, a higher incidence 
of hydrocephalus has been reported in brainstem 
tumors (19,20). In cerebellar and fourth ventricular 
tumors, hydrocephalus has been detected permanently 
(20). In developing countries, a very high incidence 
of hydrocephalus has been mentioned in brain tumor 
patients possibly indicating the diagnostic delay. 
Complicated hydrocephalus, presenting with vision 
defect, papilledema, seizure and a decreased level of 
consciousness, is the predominant problem that sends 
the child with brain tumor to the neurosurgeon (22,23). 
The drawbacks mentioned for preoperative shunting 
are namely tumor cell spreading through shunting 
systems, upward cerebellar herniation (24, 25) and 
tumor hemorrhage (23). In other studies carried out in 
developing countries, in which diagnostic delay and 
severe hydrocephalus are seen, there has been some doubt 
regarding the precise definition and actual relationship 
between the above mentioned circumstances and the 
shunting procedure (22,23).
In some studies, the fact that preoperative shunting may 
be beneficial has been suggested (21). In our limited 
study group, 34.5 % of the patients had hydrocephalus. 
It seems that the rise in ICP needs to be approached 
exclusively as it introduces a new entity in these tumors. 
A preoperative shunting procedure should be performed 
in case of concomitant hydrocephalus in patients with 
poor general and neurologic conditions. A shunt may 
decrease ICP and relax the cerebellum and make the 
tumor resection more feasible. The other benefit of 
shunt is reduction of the risk of postoperative CSF leak, 
Table 1. Clinical Presentations, Frequency and Their Mean Duration in Patients
Clinical Presentations Frequency (Percent)
Mean Duration
(Month)
Headache 62 (73.8%) 8.5
Vomiting 32 (38.1%) 3.4
Neck Stiffness 2 (2.3%) 1.2
Cerebellar Signs 68 (80.9%) 5.8
Cranial Nerve Palsy 14 (16.6 %) 3.8
Visual Problems 6 (7.14%) 2
Speech Disturbance 4 (4.7%) 2.4
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Table 2. Pathological Types of Posterior Fossa Tumor in Patients
Pathological Types No (Percent)
Medulloblastoma 36 (42.7 %)
Cerebellar Astrocytoma 24(28.6 %)
Ependymoma 12(14.3 %)
Brain Stem Glioma 6 (7.2 %)
Miscellaneous 6(7.2 %)
Total 84 (100%)
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